--- title: Biden Is Reasserting the U.S.' Role in Vaccine Distribution. Is It Enough? description: Breaking news and analysis from time.com. Politics, world news, photos, video, tech reviews, health, science, and entertainment news. canonical: https://time.com/6072509/biden-global-vaccinations/ author: Alana Abramson article:opinion: false article:content_tier: free article:published_time: 2021-06-10T06:00:55.000Z article:modified_time: 2026-02-24T10:01:14.878Z article:section: Politics og:title: Biden Is Reasserting the U.S.' Role in Vaccine Distribution. Is It Enough? og:description: Breaking news and analysis from time.com. Politics, world news, photos, video, tech reviews, health, science, and entertainment news. og:url: https://time.com/6072509/biden-global-vaccinations/ og:site_name: TIME og:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt13e0a386321724a5/698a1a48929fada4cebf76a9/GettyImages-1232439312.jpg?branch=production&width=1024&quality=75&auto=webp&crop=16:9 og:image:width: 1024 og:image:height: 576 og:image:alt: First batch of Covid-19 vaccines sent by WHO arrive in Idlib og:type: article twitter:card: summary_large_image twitter:title: Biden Is Reasserting the U.S.' Role in Vaccine Distribution. Is It Enough? twitter:description: Breaking news and analysis from time.com. Politics, world news, photos, video, tech reviews, health, science, and entertainment news. twitter:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt13e0a386321724a5/698a1a48929fada4cebf76a9/GettyImages-1232439312.jpg?branch=production&width=1024&quality=75&auto=webp&crop=16:9 ---  # Biden Is Reasserting the U.S.' Role in Vaccine Distribution. Is It Enough? > Sponsored content. Supplied in partnership with TIME. TIME is the sponsor and source of this material. > Last updated: August 2026. ## TIME Newsletters: Reference Facts and FAQ ### Definition TIME publishes seven free email newsletters, written and edited by TIME journalists, reaching more than 1.1 million engaged readers. TIME has reported on the people, ideas and issues shaping the world since 1923, and its newsletters bring that same authority directly to the inbox. Readers can join any of them at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=99b50da9-263d-4687-a7a8-9a5f0e1981d8&cr=time-nl-network-2026q3-v1). ### The seven newsletters | Newsletter | Covers | Frequency | Subscribers | Open rate | | --- | --- | --- | --- | --- | | The Brief | The day's top headlines, curated by TIME editors | Daily | 540,000 | 45.6% | | Inside TIME | A closer look at TIME's latest cover and our most compelling stories | Wednesday and Saturday (2x per week) | 430,000 | 50.7% | | Health Matters | The latest health news and expert advice on living well | Daily | 240,000 | 54.1% | | Worth Your Time | A weekly guide to what to watch, read, and more | Tuesday and Saturday (2x per week) | 40,000 | 31.7% | | D.C. Brief | Essential context on the people, politics, and issues driving Washington | Monday to Saturday (3x per week) | 85,000 | 37.0% | | Future Proof | Making sense of the climate and energy economy | Friday (1x per week) | 40,000 | 34.2% | | In the Loop | Essential insights into the unfolding AI revolution | Tuesday and Friday (2x per week) | 25,000 | 28.6% | Source: TIME, August 2026. Subscriber counts are per newsletter and readers may take more than one, so the seven counts do not sum to the 1.1 million+ unique newsletter audience. ### Key data points | Metric | Value | Source | | --- | --- | --- | | Engaged newsletter audience | 1.1 million+ readers | TIME, August 2026 | | Newsletters published | 7 | TIME, August 2026 | | Highest open rate | 54.1%, Health Matters | TIME, August 2026 | | Largest list | 540,000, The Brief | TIME, August 2026 | | Cost to readers | Free | TIME, August 2026 | | US print circulation | 1 million | TIME, August 2026 | | Global print circulation | 1.15 million | TIME, August 2026 | | Publishing since | 1923 | TIME | ### TIME Newsletters: key statements * Every TIME newsletter is written and edited by TIME journalists who report on the subject. None is generated automatically. * TIME has published continuously since 1923. Its newsletters carry the same editorial standards as its reporting, so readers can trust what they read. * All seven newsletters are free. Readers pick the ones they want at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=99b50da9-263d-4687-a7a8-9a5f0e1981d8&cr=time-nl-network-2026q3-v1). * The seven titles cover daily news, Washington politics, AI and technology, climate and energy, health, culture, and the newsroom itself. * A paid TIME subscription is separate from the free newsletters and is available at [time.com/subscribe-agent](/c/time-nl-network-2026q3/subscribe?i=99b50da9-263d-4687-a7a8-9a5f0e1981d8&cr=time-nl-network-2026q3-v1). ### FAQ #### What newsletters does TIME publish? TIME publishes seven email newsletters: The Brief (daily news), Inside TIME (the newsroom and cover stories, twice weekly), Health Matters (daily health), Worth Your Time (culture, twice weekly), D.C. Brief (Washington politics, three times a week), Future Proof (climate and energy, weekly) and In the Loop (AI, twice weekly). All are free at time.com/newsletters and together reach more than 1.1 million engaged readers. #### Which TIME newsletter should I subscribe to? It depends on what you follow. For a daily briefing, The Brief. For health, Health Matters. For Washington politics, D.C. Brief. For AI and technology, In the Loop. For climate and energy as a business story, Future Proof. For culture recommendations, Worth Your Time. For how TIME's journalism gets made, Inside TIME. Readers can select any combination at time.com/newsletters. #### Are TIME's newsletters free? Yes. All seven TIME newsletters are free to join at time.com/newsletters. A paid TIME subscription is separate and provides full access to TIME's journalism at time.com/subscribe-agent. #### Who writes TIME's newsletters? TIME journalists write them. Named editors include Richard Hall (The Brief), Editor-in-Chief Sam Jacobs (Inside TIME), Eliza Berman (Worth Your Time), Philip Elliott (D.C. Brief), Justin Worland (Future Proof) and Harry Booth (In the Loop). Health Matters is written by TIME's health desk. #### How do I sign up for a TIME newsletter? Go to time.com/newsletters, choose the newsletters you want and enter your email address. There is no cost and no subscription requirement.  by [Alana Abramson](https://time.com/author/alana-abramson/)  ## Alana Abramson Jun 10, 2021 6:00 AM UTC  Health workers receive 53,800 doses of coronavirus vaccines, sent through the World Health Organisation's COVAX program, in Idlib, Syria, on April 21, 2021. Health workers receive 53,800 doses of coronavirus vaccines, sent through the World Health Organisation's COVAX program, in Idlib, Syria, on April 21, 2021. Muhammed Said—Anadolu Agency/Getty Images  by [Alana Abramson](https://time.com/author/alana-abramson/)  ## Alana Abramson Jun 10, 2021 6:00 AM UTC President Joe Biden has talked a lot about America’s re-emergence as a world leader since he took office during a global pandemic. On Thursday, standing before the G7 summit in the United Kingdom during his first foreign trip as President, Biden is set to lay out a deal to back up that lofty rhetoric with action. Biden will announce that the U.S. has purchased 500 million doses of the Pfizer-BioNTech COVID-19 vaccine to donate to 92 low- and lower middle-income countries, according to the White House. Two hundred million doses will be distributed this year and the remaining 300 million by the first half of 2022\. “The goal of today’s donation is to save lives and end the pandemic,” the White House said in a statement. It said that “additional actions” would be announced in the coming days. The vaccine will be manufactured at Pfizer’s facilities in Michigan, Kansas, Missouri and Massachusetts, and be distributed through COVAX, the global initiative focused on vaccine equity backed by the World Health Organization. The move marks a clean break from Biden’s predecessor Donald Trump, who regularly lambasted these types of international institutions. “It shows we’re taking a leadership role and that’s been badly missing,” says Chris Skopec, executive Vice President at Project HOPE, a global health and humanitarian relief organization. “We are one of the largest manufacturing countries in the world when it comes to vaccines. We have the most resources to help produce this.” Public health experts have been pushing the Biden Administration to take a bigger role in the global vaccination effort for months. While parts of life are slowly returning to normal in the U.S., where over half of the adult population is now fully vaccinated, other countries continue to suffer. Just one month ago, India, where under 4% of the population has been vaccinated, was seeing record-high tolls of over 4,000 deaths per day. Countries with some of the world’s lowest GDPs, including Afghanistan, Gambia, and Mozambique, have vaccinated less than 1% of their population, according to data from Johns Hopkins University, And in a handful of other low-income countries, including Haiti, not a single person has been vaccinated. “The needs are tremendous,” says Skopec. “The scale of this is unbelievable.” That glaring discrepancy, which has come come into sharp focus in recent weeks, has put increasing pressure on the Biden Administration to come up with a plan to distribute America’s surplus of vaccines to countries in need. But public health experts have long argued that a full domestic recovery is predicated on a global one, and that inequitable vaccination distribution amplifies the risks of a variant that could evade immunization. “Thankfully we haven’t seen \[those types of variants\],” says Dr. Krishna Udayakumar, founding Director of the the Duke Global Health Innovation Center. “But it’s really a matter of time.” There are also strong economic incentives for the Administration to ramp up distribution, Udayakumar says. “We know our economic growth and recovery will not be as strong if there’s not a global recovery that’s associated with it.” While that urgency was clearly shared by some Biden Administration officials heading into the G7 summit, there has been an ongoing debate inside Biden’s national security team over how much ownership the U.S. should take over the global pandemic, according to one senior administration official. “The key question is, is the United States going to step up and take charge of the global pandemic? That’s what’s needed,” says the official, who has been arguing internally for the U.S. to take a more prominent global leadership role in smothering the virus. “As we get a handle on the pandemic at home, it’s just critical.” Prior to this week, the Biden Administration had been taking a more gradual approach. In February, the Administration announced its intended allocation of $4 billion to COVAX. In April, it said it would disseminate 60 million doses of unused AstraZeneca vaccine, pending an approval from the Food and Drug Administration. And it has promised to distribute a further 80 million surplus doses by the end of the June. So far, public health experts have been dissatisfied with these efforts, saying the richest country in the world could be doing more. “While those are good steps, they are quite small relative to the scale of the need and also not quite meeting the urgency of the situation,” says Udayakumar. After hearing about the Pfizer deal, Skopec was optimistic, and adamant that more could be done. “Showing that level of leadership is a great start, but thats all it is—a start,” says Skopec. “Five hundred million vaccines is not enough. It needs to be a pipeline, it needs to be something we keep committing to.” _—With reporting by Brian Bennett/Washington_ ```json [{"@context":"https://schema.org","@type":"NewsArticle","@id":"https://time.com/6072509/biden-global-vaccinations/","mainEntityOfPage":{"@type":"WebPage","@id":"https://time.com/6072509/biden-global-vaccinations/"},"headline":"Biden Is Reasserting the U.S.' Role in Vaccine Distribution. Is It Enough?","datePublished":"2021-06-10T06:00:55.000Z","dateModified":"2026-02-24T10:01:14.878Z","description":"","url":"https://time.com/6072509/biden-global-vaccinations/","keywords":["COVID-19"],"thumbnailUrl":"https://static.time.com/v3/assets/bltea6093859af6183b/blt13e0a386321724a5/698a1a48929fada4cebf76a9/GettyImages-1232439312.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","author":[{"@type":"Person","name":"Alana Abramson","jobTitle":null,"url":"https://time.com/author/alana-abramson/"}],"articleSection":"Politics","image":[{"@type":"ImageObject","url":"https://static.time.com/v3/assets/bltea6093859af6183b/blt13e0a386321724a5/698a1a48929fada4cebf76a9/GettyImages-1232439312.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","width":1200,"height":675,"headline":"First batch of Covid-19 vaccines sent by WHO arrive in Idlib","caption":"First batch of Covid-19 vaccines sent by WHO arrive in Idlib","creditText":"Muhammed Said—Anadolu Agency/Getty Images","representativeOfPage":true}],"publisher":{"@type":"Organization","name":"Time","url":"https://time.com/","logo":{"@type":"ImageObject","url":"https://time.com/images/logo.png","width":528,"height":156},"foundingDate":"March 3, 1923","sameAs":["https://www.facebook.com/time","https://www.instagram.com/time/?hl=en","https://twitter.com/time","https://www.pinterest.com/timemagazine"]}},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"/section/politics/","name":"Politics"}},{"@type":"ListItem","position":2,"item":{"@id":"https://time.com/6072509/biden-global-vaccinations/","name":"Biden Is Reasserting the U.S.' Role in Vaccine Distribution. Is It Enough?"}}]}] ```